Advances in Psoriasis : A Multisystemic Guide / edited by Jeffrey M. Weinberg, Mark Lebwohl
Introduction to and History of Psoriasis and Psoriasis Therapy -- Pathophysiology of Psoriasis/Novel Pathways -- Psoriasis: Clinical Review and Update -- Psoriasis: Epidemiology, Potential Triggers, Disease Course -- Topical Therapy I: Corticosteroids and Vitamin D Analogues -- Topical Therapy II: Retinoids, Immunomodulators, and Others -- Topical Therapy II: Retinoids, Immunomuodulators, and Others/ Ultraviolet Therapy for Psoriasis -- Laser Therapy for Psoriasis -- Traditional Systemic Therapy I: Methotrexate and Cyclosporine -- Traditional Systemic Therapy II: Retinoids and Others -- Apremilast -- Etanercept -- Adalimumab -- Infliximab, Golimumab , and Certolizumab Pegol -- Ustekinumab -- Guselkumab -- Tidrakizumab -- Risankizumab -- Secukinumab -- Ixekizumab -- Brodalumab -- Biosimilars for Psoriasis -- Research Pipeline I: Oral Therapeutics for Psoriasis -- Research Pipeline II: Upcoming Biologic Therapies -- Pediatric Psoriasis -- Challenges in Psoriasis Treatment: Nail, Scalp, and Palmoplantar Involvement -- Psoriasis and Comorbidities -- Summary of Published Treatment Guidelines -- Index..
This extensively revised second edition provides an up-to-date and highly informative textbook on psoriasis. The understanding of the mechanisms behind the disease and the available treatment options have continued to develop rapidly in recent times, with this vital resource covering the latest in these management options, including targeted T-cell therapy, the use of immunomodulators, systemic therapies, and ultraviolet and laser therapy. In addition, it provides a detailed overview of the pathophysiology, comorbidities, epidemiology and triggers of the disease. Advances in Psoriasis: A Multisystemic Guide extensively details the scientific basis and practice management of psoriasis. It is therefore a vital resource for practicing and trainee dermatologists looking to develop their clinical knowledge of how to manage and treat these patients..
| Medienart: |
E-Book |
|---|
| Erscheinungsjahr: |
2021. |
|---|---|
| Erschienen: |
Cham: Springer International Publishing ; 2021. Cham: Imprint: Springer ; 2021. |
| Ausgabe: |
2nd ed. 2021. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Weinberg, Jeffrey M. [HerausgeberIn] |
|---|
| Links: |
|---|
| ISBN: |
|---|
| Themen: |
|---|
| Umfang: |
1 Online-Ressource(VI, 423 p. 54 illus., 45 illus. in color.) |
|---|
| doi: |
10.1007/978-3-030-54859-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
174158311X |
|---|
| LEADER | 01000cam a22002652 4500 | ||
|---|---|---|---|
| 001 | 174158311X | ||
| 003 | DE-627 | ||
| 005 | 20230427060713.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201201s2021 gw |||||o 00| ||eng c | ||
| 020 | |a 9783030548599 |9 978-3-030-54859-9 | ||
| 024 | 7 | |a 10.1007/978-3-030-54859-9 |2 doi | |
| 035 | |a (DE-627)174158311X | ||
| 035 | |a (DE-599)KEP060100613 | ||
| 035 | |a (DE-He213)978-3-030-54859-9 | ||
| 035 | |a (EBP)060100613 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 044 | |c XA-DE | ||
| 072 | 7 | |a MJK |2 bicssc | |
| 072 | 7 | |a MED017000 |2 bisacsh | |
| 245 | 1 | 0 | |a Advances in Psoriasis |b A Multisystemic Guide |c edited by Jeffrey M. Weinberg, Mark Lebwohl |
| 250 | |a 2nd ed. 2021. | ||
| 264 | 1 | |a Cham |b Springer International Publishing |c 2021. | |
| 264 | 1 | |a Cham |b Imprint: Springer |c 2021. | |
| 300 | |a 1 Online-Ressource(VI, 423 p. 54 illus., 45 illus. in color.) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Introduction to and History of Psoriasis and Psoriasis Therapy -- Pathophysiology of Psoriasis/Novel Pathways -- Psoriasis: Clinical Review and Update -- Psoriasis: Epidemiology, Potential Triggers, Disease Course -- Topical Therapy I: Corticosteroids and Vitamin D Analogues -- Topical Therapy II: Retinoids, Immunomodulators, and Others -- Topical Therapy II: Retinoids, Immunomuodulators, and Others/ Ultraviolet Therapy for Psoriasis -- Laser Therapy for Psoriasis -- Traditional Systemic Therapy I: Methotrexate and Cyclosporine -- Traditional Systemic Therapy II: Retinoids and Others -- Apremilast -- Etanercept -- Adalimumab -- Infliximab, Golimumab , and Certolizumab Pegol -- Ustekinumab -- Guselkumab -- Tidrakizumab -- Risankizumab -- Secukinumab -- Ixekizumab -- Brodalumab -- Biosimilars for Psoriasis -- Research Pipeline I: Oral Therapeutics for Psoriasis -- Research Pipeline II: Upcoming Biologic Therapies -- Pediatric Psoriasis -- Challenges in Psoriasis Treatment: Nail, Scalp, and Palmoplantar Involvement -- Psoriasis and Comorbidities -- Summary of Published Treatment Guidelines -- Index. | ||
| 520 | |a This extensively revised second edition provides an up-to-date and highly informative textbook on psoriasis. The understanding of the mechanisms behind the disease and the available treatment options have continued to develop rapidly in recent times, with this vital resource covering the latest in these management options, including targeted T-cell therapy, the use of immunomodulators, systemic therapies, and ultraviolet and laser therapy. In addition, it provides a detailed overview of the pathophysiology, comorbidities, epidemiology and triggers of the disease. Advances in Psoriasis: A Multisystemic Guide extensively details the scientific basis and practice management of psoriasis. It is therefore a vital resource for practicing and trainee dermatologists looking to develop their clinical knowledge of how to manage and treat these patients. | ||
| 650 | 0 | |a Dermatology. | |
| 650 | 0 | |a Pharmacotherapy. | |
| 650 | 0 | |a Immunology. | |
| 700 | 1 | |a Weinberg, Jeffrey M. |e herausgeberin |4 edt | |
| 700 | 1 | |a Lebwohl, Mark |e herausgeberin |4 edt | |
| 776 | 1 | |z 9783030548582 | |
| 776 | 1 | |z 9783030548605 | |
| 776 | 1 | |z 9783030548612 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783030548582 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783030548605 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783030548612 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-030-54859-9 |m X:SPRINGER |x Resolving-System |z lizenzpflichtig |
| 856 | 4 | 2 | |u https://swbplus.bsz-bw.de/bsz174158311xcov.jpg |m V:DE-576 |m X:SPRINGER |q image/jpeg |v 20211202162153 |3 Cover |
| 912 | |a ZDB-2-SEB |b 2021 | ||
| 912 | |a ZDB-2-SME |b 2021 | ||
| 912 | |a ZDB-2-SXM |b 2021 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a ISIL_DE-18 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_22_i06404 | ||
| 912 | |a GBV_ILN_62 | ||
| 912 | |a ISIL_DE-28 | ||
| 912 | |a GBV_ILN_120 | ||
| 912 | |a ISIL_DE-715 | ||
| 912 | |a GBV_ILN_130 | ||
| 912 | |a ISIL_DE-700 | ||
| 912 | |a GBV_ILN_2003 | ||
| 912 | |a ISIL_DE-25 | ||
| 912 | |a GBV_ILN_2006 | ||
| 912 | |a ISIL_DE-14 | ||
| 912 | |a GBV_ILN_2011 | ||
| 912 | |a ISIL_DE-16 | ||
| 912 | |a GBV_ILN_2017 | ||
| 912 | |a ISIL_DE-576 | ||
| 912 | |a GBV_ILN_2141 | ||
| 912 | |a ISIL_DE-16-300 | ||
| 951 | |a BO | ||
| 953 | |2 045F |a 616.5 | ||
| 980 | |2 22 |1 01 |x 0018 |b 3831375364 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |k Campuslizenz Universität Hamburg. - Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y zi06404 |z 06-01-21 | ||
| 980 | |2 62 |1 01 |x 0028 |b 4017721907 |h OLR-SME |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Die Weitergabe an Dritte sowie systematisches Downloaden sind untersagt. |y z |z 09-12-21 | ||
| 980 | |2 120 |1 01 |x 0715 |b 3826391802 |c 00 |f --%%-- |d --%%-- |e g |j --%%-- |h alma |y z |z 17-12-20 | ||
| 980 | |2 130 |1 01 |x 0700 |b 383401267X |h OLR-SEB |k Vervielfältigungen (z. B. Kopien, Downloads) nur für den eigenen wissenschaftlichen Gebrauch. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots |y z |z 10-01-21 | ||
| 980 | |2 2003 |1 01 |x DE-25 |b 4002321045 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Elektronischer Volltext - Universitätslizenz |y l01 |z 16-11-21 | ||
| 980 | |2 2006 |1 01 |x DE-14 |b 3815573327 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 01-12-20 | ||
| 980 | |2 2011 |1 01 |x DE-16 |b 3832701702 |c 00 |f --%%-- |d --%%-- |e --%%-- |j knp |y l01 |z 08-01-21 | ||
| 980 | |2 2017 |1 01 |x DE-576 |b 3815573335 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Besitznachweis BSZ nur für Dateneinspielung, keine echte Lizenz vorhanden |y l01 |z 01-12-20 | ||
| 980 | |2 2141 |1 01 |x DE-16-300 |b 3832701710 |c 00 |f --%%-- |d --%%-- |e --%%-- |j knp |y l01 |z 08-01-21 | ||
| 981 | |2 22 |1 01 |x 0018 |y Volltextzugang |r https://doi.org/10.1007/978-3-030-54859-9 | ||
| 981 | |2 22 |1 01 |x 0018 |y Nur für Angehörige der Universität Hamburg: Volltextzugang von außerhalb des Campus |r http://emedien.sub.uni-hamburg.de/han/SpringerEbooksUKE/doi.org/10.1007/978-3-030-54859-9 | ||
| 981 | |2 62 |1 01 |x 0028 |r https://doi.org/10.1007/978-3-030-54859-9 | ||
| 981 | |2 120 |1 01 |x 0715 |r http://49gbv-uob-primo.hosted.exlibrisgroup.com/openurl/49GBV_UOB/UOB_services_page?u.ignore_date_coverage=true&rft.mms_id=991015068788603501 | ||
| 981 | |2 130 |1 01 |x 0700 |r https://doi.org/10.1007/978-3-030-54859-9 | ||
| 981 | |2 2003 |1 01 |x DE-25 |r https://www.redi-bw.de/start/unifr/EBooks-springer/10.1007/978-3-030-54859-9 | ||
| 981 | |2 2006 |1 01 |x DE-14 |r https://doi.org/10.1007/978-3-030-54859-9 | ||
| 981 | |2 2011 |1 01 |x DE-16 |r https://doi.org/10.1007/978-3-030-54859-9 | ||
| 981 | |2 2141 |1 01 |x DE-16-300 |r https://doi.org/10.1007/978-3-030-54859-9 | ||
| 985 | |2 22 |1 01 |x 0018 |a h64 ebook | ||
| 995 | |2 62 |1 01 |x 0028 |a OLR-SME | ||
| 995 | |2 120 |1 01 |x 0715 |a alma | ||
| 995 | |2 130 |1 01 |x 0700 |a OLR-SEB | ||
| 998 | |2 2003 |1 01 |x DE-25 |0 16-11-21 |f 18 | ||